Email this article to a friend
Towards an anti-fibrotic therapy for scleroderma: targeting myofibroblast differentiation and recruitment
-
Correspondence: Andrew Leask andrew.leask@schulich.uwo.ca
Fibrogenesis & Tissue Repair 2010, 3:8 doi:10.1186/1755-1536-3-8